LOGO
LOGO

WebMD Begins Tender Offer To Buy Back Approx. 10% Shares - Update

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Tuesday, health information service provider WebMD Health Corp. (WBMD) said it began a tender offer to buy up to 5.7 million shares at a price of $37 a share, higher than the $36 per share proposed on November 3. The tender offer will expire on Dec. 10.

The New-York based company said the number of shares proposed to be purchased in the tender offer represents around 10% of WebMD's currently outstanding common shares. The last reported sales price per share of WebMD's common stock on the Nasdaq Global Select Market on November 9, 2009 was $35.75 per share.

Following the merger with Elmwood Park, New Jersey-based HLTH Corp. (HLTH ), WebMD has nearly $1 billion in cash and investments, and will use a portion to fund the tender offer.

While reporting its results earlier this month, WebMD reported a rise in profit for the third quarter, as revenues increased 15% from last year on higher advertising revenues. The company also reiterated its earnings forecast for fiscal year 2009, as well as its fourth quarter.

WBMD is currently trading at $36.17, up $0.42 or 1.17%, on a volume of 0.11 million shares. In the past 52 weeks, the stock trended in a broad range of $13.63 - $36.39, with a three-month average volume of 0.11 million shares.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19